Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Different Uric Acid-Lowering Drugs on Gout Flare
ChiCTR2100044828Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of febuxostat, allopurinol and benzbromarone in gout (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: frequency of gout flare. Started Sep 2020; status: recruiting.
02
Drugs
febuxostatallopurinolbenzbromarone
03
Conditions
gout
Beyond the preview
Go deeper on ChiCTR2100044828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044828.